Global Human Vaccine Market Research Report 2024(Status and Outlook)
Report Overview
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
This report provides a deep insight into the global Human Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Vaccine market in any manner.
Global Human Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
ZhongKe Biopharm
Zhuoyi Biological
Market Segmentation (by Type)
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
by Application
Market Segmentation (by Application)
Adults
Children
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
This report provides a deep insight into the global Human Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Vaccine market in any manner.
Global Human Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
ZhongKe Biopharm
Zhuoyi Biological
Market Segmentation (by Type)
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
by Application
Market Segmentation (by Application)
Adults
Children
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Human Vaccine Market
- Overview of the regional outlook of the Human Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Human Vaccine
1.2 Key Market Segments
1.2.1 Human Vaccine Segment by Type
1.2.2 Human Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Human Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Vaccine Sales Sites, Area Served, Product Type
3.6 Human Vaccine Market Competitive Situation and Trends
3.6.1 Human Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Human Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Human Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Human Vaccine Price by Type (2019-2024)
7 HUMAN VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Vaccine Market Sales by Application (2019-2024)
7.3 Global Human Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Human Vaccine Sales Growth Rate by Application (2019-2024)
8 HUMAN VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Human Vaccine Sales by Region
8.1.1 Global Human Vaccine Sales by Region
8.1.2 Global Human Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Human Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CNBG
9.1.1 CNBG Human Vaccine Basic Information
9.1.2 CNBG Human Vaccine Product Overview
9.1.3 CNBG Human Vaccine Product Market Performance
9.1.4 CNBG Business Overview
9.1.5 CNBG Human Vaccine SWOT Analysis
9.1.6 CNBG Recent Developments
9.2 Changsheng Life
9.2.1 Changsheng Life Human Vaccine Basic Information
9.2.2 Changsheng Life Human Vaccine Product Overview
9.2.3 Changsheng Life Human Vaccine Product Market Performance
9.2.4 Changsheng Life Business Overview
9.2.5 Changsheng Life Human Vaccine SWOT Analysis
9.2.6 Changsheng Life Recent Developments
9.3 Zhifei
9.3.1 Zhifei Human Vaccine Basic Information
9.3.2 Zhifei Human Vaccine Product Overview
9.3.3 Zhifei Human Vaccine Product Market Performance
9.3.4 Zhifei Human Vaccine SWOT Analysis
9.3.5 Zhifei Business Overview
9.3.6 Zhifei Recent Developments
9.4 ChengDa Bio
9.4.1 ChengDa Bio Human Vaccine Basic Information
9.4.2 ChengDa Bio Human Vaccine Product Overview
9.4.3 ChengDa Bio Human Vaccine Product Market Performance
9.4.4 ChengDa Bio Business Overview
9.4.5 ChengDa Bio Recent Developments
9.5 Kangtai
9.5.1 Kangtai Human Vaccine Basic Information
9.5.2 Kangtai Human Vaccine Product Overview
9.5.3 Kangtai Human Vaccine Product Market Performance
9.5.4 Kangtai Business Overview
9.5.5 Kangtai Recent Developments
9.6 SINOVAC BIOTECH
9.6.1 SINOVAC BIOTECH Human Vaccine Basic Information
9.6.2 SINOVAC BIOTECH Human Vaccine Product Overview
9.6.3 SINOVAC BIOTECH Human Vaccine Product Market Performance
9.6.4 SINOVAC BIOTECH Business Overview
9.6.5 SINOVAC BIOTECH Recent Developments
9.7 Hissen
9.7.1 Hissen Human Vaccine Basic Information
9.7.2 Hissen Human Vaccine Product Overview
9.7.3 Hissen Human Vaccine Product Market Performance
9.7.4 Hissen Business Overview
9.7.5 Hissen Recent Developments
9.8 Walvax Biotechnology
9.8.1 Walvax Biotechnology Human Vaccine Basic Information
9.8.2 Walvax Biotechnology Human Vaccine Product Overview
9.8.3 Walvax Biotechnology Human Vaccine Product Market Performance
9.8.4 Walvax Biotechnology Business Overview
9.8.5 Walvax Biotechnology Recent Developments
9.9 GSK
9.9.1 GSK Human Vaccine Basic Information
9.9.2 GSK Human Vaccine Product Overview
9.9.3 GSK Human Vaccine Product Market Performance
9.9.4 GSK Business Overview
9.9.5 GSK Recent Developments
9.10 SANOFI
9.10.1 SANOFI Human Vaccine Basic Information
9.10.2 SANOFI Human Vaccine Product Overview
9.10.3 SANOFI Human Vaccine Product Market Performance
9.10.4 SANOFI Business Overview
9.10.5 SANOFI Recent Developments
9.11 Rong An
9.11.1 Rong An Human Vaccine Basic Information
9.11.2 Rong An Human Vaccine Product Overview
9.11.3 Rong An Human Vaccine Product Market Performance
9.11.4 Rong An Business Overview
9.11.5 Rong An Recent Developments
9.12 NuoCheng Bio
9.12.1 NuoCheng Bio Human Vaccine Basic Information
9.12.2 NuoCheng Bio Human Vaccine Product Overview
9.12.3 NuoCheng Bio Human Vaccine Product Market Performance
9.12.4 NuoCheng Bio Business Overview
9.12.5 NuoCheng Bio Recent Developments
9.13 Hualan Bio
9.13.1 Hualan Bio Human Vaccine Basic Information
9.13.2 Hualan Bio Human Vaccine Product Overview
9.13.3 Hualan Bio Human Vaccine Product Market Performance
9.13.4 Hualan Bio Business Overview
9.13.5 Hualan Bio Recent Developments
9.14 Tiantan biological
9.14.1 Tiantan biological Human Vaccine Basic Information
9.14.2 Tiantan biological Human Vaccine Product Overview
9.14.3 Tiantan biological Human Vaccine Product Market Performance
9.14.4 Tiantan biological Business Overview
9.14.5 Tiantan biological Recent Developments
9.15 Changchun Baike
9.15.1 Changchun Baike Human Vaccine Basic Information
9.15.2 Changchun Baike Human Vaccine Product Overview
9.15.3 Changchun Baike Human Vaccine Product Market Performance
9.15.4 Changchun Baike Business Overview
9.15.5 Changchun Baike Recent Developments
9.16 Adimmune
9.16.1 Adimmune Human Vaccine Basic Information
9.16.2 Adimmune Human Vaccine Product Overview
9.16.3 Adimmune Human Vaccine Product Market Performance
9.16.4 Adimmune Business Overview
9.16.5 Adimmune Recent Developments
9.17 Zhongyianke Biotech
9.17.1 Zhongyianke Biotech Human Vaccine Basic Information
9.17.2 Zhongyianke Biotech Human Vaccine Product Overview
9.17.3 Zhongyianke Biotech Human Vaccine Product Market Performance
9.17.4 Zhongyianke Biotech Business Overview
9.17.5 Zhongyianke Biotech Recent Developments
9.18 Bharat Biotech
9.18.1 Bharat Biotech Human Vaccine Basic Information
9.18.2 Bharat Biotech Human Vaccine Product Overview
9.18.3 Bharat Biotech Human Vaccine Product Market Performance
9.18.4 Bharat Biotech Business Overview
9.18.5 Bharat Biotech Recent Developments
9.19 Bavarian Nordic
9.19.1 Bavarian Nordic Human Vaccine Basic Information
9.19.2 Bavarian Nordic Human Vaccine Product Overview
9.19.3 Bavarian Nordic Human Vaccine Product Market Performance
9.19.4 Bavarian Nordic Business Overview
9.19.5 Bavarian Nordic Recent Developments
9.20 Sanofi-Pasteur
9.20.1 Sanofi-Pasteur Human Vaccine Basic Information
9.20.2 Sanofi-Pasteur Human Vaccine Product Overview
9.20.3 Sanofi-Pasteur Human Vaccine Product Market Performance
9.20.4 Sanofi-Pasteur Business Overview
9.20.5 Sanofi-Pasteur Recent Developments
9.21 Indian Immunologicals
9.21.1 Indian Immunologicals Human Vaccine Basic Information
9.21.2 Indian Immunologicals Human Vaccine Product Overview
9.21.3 Indian Immunologicals Human Vaccine Product Market Performance
9.21.4 Indian Immunologicals Business Overview
9.21.5 Indian Immunologicals Recent Developments
9.22 KANGH
9.22.1 KANGH Human Vaccine Basic Information
9.22.2 KANGH Human Vaccine Product Overview
9.22.3 KANGH Human Vaccine Product Market Performance
9.22.4 KANGH Business Overview
9.22.5 KANGH Recent Developments
9.23 Henan Grand Biopharma
9.23.1 Henan Grand Biopharma Human Vaccine Basic Information
9.23.2 Henan Grand Biopharma Human Vaccine Product Overview
9.23.3 Henan Grand Biopharma Human Vaccine Product Market Performance
9.23.4 Henan Grand Biopharma Business Overview
9.23.5 Henan Grand Biopharma Recent Developments
9.24 ZhongKe Biopharm
9.24.1 ZhongKe Biopharm Human Vaccine Basic Information
9.24.2 ZhongKe Biopharm Human Vaccine Product Overview
9.24.3 ZhongKe Biopharm Human Vaccine Product Market Performance
9.24.4 ZhongKe Biopharm Business Overview
9.24.5 ZhongKe Biopharm Recent Developments
9.25 Zhuoyi Biological
9.25.1 Zhuoyi Biological Human Vaccine Basic Information
9.25.2 Zhuoyi Biological Human Vaccine Product Overview
9.25.3 Zhuoyi Biological Human Vaccine Product Market Performance
9.25.4 Zhuoyi Biological Business Overview
9.25.5 Zhuoyi Biological Recent Developments
10 HUMAN VACCINE MARKET FORECAST BY REGION
10.1 Global Human Vaccine Market Size Forecast
10.2 Global Human Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Human Vaccine Market Size Forecast by Region
10.2.4 South America Human Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Human Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Vaccine by Type (2025-2030)
11.1.2 Global Human Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Vaccine by Type (2025-2030)
11.2 Global Human Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Human Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Human Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Human Vaccine
1.2 Key Market Segments
1.2.1 Human Vaccine Segment by Type
1.2.2 Human Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Human Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Vaccine Sales Sites, Area Served, Product Type
3.6 Human Vaccine Market Competitive Situation and Trends
3.6.1 Human Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Human Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Human Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Human Vaccine Price by Type (2019-2024)
7 HUMAN VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Vaccine Market Sales by Application (2019-2024)
7.3 Global Human Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Human Vaccine Sales Growth Rate by Application (2019-2024)
8 HUMAN VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Human Vaccine Sales by Region
8.1.1 Global Human Vaccine Sales by Region
8.1.2 Global Human Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Human Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CNBG
9.1.1 CNBG Human Vaccine Basic Information
9.1.2 CNBG Human Vaccine Product Overview
9.1.3 CNBG Human Vaccine Product Market Performance
9.1.4 CNBG Business Overview
9.1.5 CNBG Human Vaccine SWOT Analysis
9.1.6 CNBG Recent Developments
9.2 Changsheng Life
9.2.1 Changsheng Life Human Vaccine Basic Information
9.2.2 Changsheng Life Human Vaccine Product Overview
9.2.3 Changsheng Life Human Vaccine Product Market Performance
9.2.4 Changsheng Life Business Overview
9.2.5 Changsheng Life Human Vaccine SWOT Analysis
9.2.6 Changsheng Life Recent Developments
9.3 Zhifei
9.3.1 Zhifei Human Vaccine Basic Information
9.3.2 Zhifei Human Vaccine Product Overview
9.3.3 Zhifei Human Vaccine Product Market Performance
9.3.4 Zhifei Human Vaccine SWOT Analysis
9.3.5 Zhifei Business Overview
9.3.6 Zhifei Recent Developments
9.4 ChengDa Bio
9.4.1 ChengDa Bio Human Vaccine Basic Information
9.4.2 ChengDa Bio Human Vaccine Product Overview
9.4.3 ChengDa Bio Human Vaccine Product Market Performance
9.4.4 ChengDa Bio Business Overview
9.4.5 ChengDa Bio Recent Developments
9.5 Kangtai
9.5.1 Kangtai Human Vaccine Basic Information
9.5.2 Kangtai Human Vaccine Product Overview
9.5.3 Kangtai Human Vaccine Product Market Performance
9.5.4 Kangtai Business Overview
9.5.5 Kangtai Recent Developments
9.6 SINOVAC BIOTECH
9.6.1 SINOVAC BIOTECH Human Vaccine Basic Information
9.6.2 SINOVAC BIOTECH Human Vaccine Product Overview
9.6.3 SINOVAC BIOTECH Human Vaccine Product Market Performance
9.6.4 SINOVAC BIOTECH Business Overview
9.6.5 SINOVAC BIOTECH Recent Developments
9.7 Hissen
9.7.1 Hissen Human Vaccine Basic Information
9.7.2 Hissen Human Vaccine Product Overview
9.7.3 Hissen Human Vaccine Product Market Performance
9.7.4 Hissen Business Overview
9.7.5 Hissen Recent Developments
9.8 Walvax Biotechnology
9.8.1 Walvax Biotechnology Human Vaccine Basic Information
9.8.2 Walvax Biotechnology Human Vaccine Product Overview
9.8.3 Walvax Biotechnology Human Vaccine Product Market Performance
9.8.4 Walvax Biotechnology Business Overview
9.8.5 Walvax Biotechnology Recent Developments
9.9 GSK
9.9.1 GSK Human Vaccine Basic Information
9.9.2 GSK Human Vaccine Product Overview
9.9.3 GSK Human Vaccine Product Market Performance
9.9.4 GSK Business Overview
9.9.5 GSK Recent Developments
9.10 SANOFI
9.10.1 SANOFI Human Vaccine Basic Information
9.10.2 SANOFI Human Vaccine Product Overview
9.10.3 SANOFI Human Vaccine Product Market Performance
9.10.4 SANOFI Business Overview
9.10.5 SANOFI Recent Developments
9.11 Rong An
9.11.1 Rong An Human Vaccine Basic Information
9.11.2 Rong An Human Vaccine Product Overview
9.11.3 Rong An Human Vaccine Product Market Performance
9.11.4 Rong An Business Overview
9.11.5 Rong An Recent Developments
9.12 NuoCheng Bio
9.12.1 NuoCheng Bio Human Vaccine Basic Information
9.12.2 NuoCheng Bio Human Vaccine Product Overview
9.12.3 NuoCheng Bio Human Vaccine Product Market Performance
9.12.4 NuoCheng Bio Business Overview
9.12.5 NuoCheng Bio Recent Developments
9.13 Hualan Bio
9.13.1 Hualan Bio Human Vaccine Basic Information
9.13.2 Hualan Bio Human Vaccine Product Overview
9.13.3 Hualan Bio Human Vaccine Product Market Performance
9.13.4 Hualan Bio Business Overview
9.13.5 Hualan Bio Recent Developments
9.14 Tiantan biological
9.14.1 Tiantan biological Human Vaccine Basic Information
9.14.2 Tiantan biological Human Vaccine Product Overview
9.14.3 Tiantan biological Human Vaccine Product Market Performance
9.14.4 Tiantan biological Business Overview
9.14.5 Tiantan biological Recent Developments
9.15 Changchun Baike
9.15.1 Changchun Baike Human Vaccine Basic Information
9.15.2 Changchun Baike Human Vaccine Product Overview
9.15.3 Changchun Baike Human Vaccine Product Market Performance
9.15.4 Changchun Baike Business Overview
9.15.5 Changchun Baike Recent Developments
9.16 Adimmune
9.16.1 Adimmune Human Vaccine Basic Information
9.16.2 Adimmune Human Vaccine Product Overview
9.16.3 Adimmune Human Vaccine Product Market Performance
9.16.4 Adimmune Business Overview
9.16.5 Adimmune Recent Developments
9.17 Zhongyianke Biotech
9.17.1 Zhongyianke Biotech Human Vaccine Basic Information
9.17.2 Zhongyianke Biotech Human Vaccine Product Overview
9.17.3 Zhongyianke Biotech Human Vaccine Product Market Performance
9.17.4 Zhongyianke Biotech Business Overview
9.17.5 Zhongyianke Biotech Recent Developments
9.18 Bharat Biotech
9.18.1 Bharat Biotech Human Vaccine Basic Information
9.18.2 Bharat Biotech Human Vaccine Product Overview
9.18.3 Bharat Biotech Human Vaccine Product Market Performance
9.18.4 Bharat Biotech Business Overview
9.18.5 Bharat Biotech Recent Developments
9.19 Bavarian Nordic
9.19.1 Bavarian Nordic Human Vaccine Basic Information
9.19.2 Bavarian Nordic Human Vaccine Product Overview
9.19.3 Bavarian Nordic Human Vaccine Product Market Performance
9.19.4 Bavarian Nordic Business Overview
9.19.5 Bavarian Nordic Recent Developments
9.20 Sanofi-Pasteur
9.20.1 Sanofi-Pasteur Human Vaccine Basic Information
9.20.2 Sanofi-Pasteur Human Vaccine Product Overview
9.20.3 Sanofi-Pasteur Human Vaccine Product Market Performance
9.20.4 Sanofi-Pasteur Business Overview
9.20.5 Sanofi-Pasteur Recent Developments
9.21 Indian Immunologicals
9.21.1 Indian Immunologicals Human Vaccine Basic Information
9.21.2 Indian Immunologicals Human Vaccine Product Overview
9.21.3 Indian Immunologicals Human Vaccine Product Market Performance
9.21.4 Indian Immunologicals Business Overview
9.21.5 Indian Immunologicals Recent Developments
9.22 KANGH
9.22.1 KANGH Human Vaccine Basic Information
9.22.2 KANGH Human Vaccine Product Overview
9.22.3 KANGH Human Vaccine Product Market Performance
9.22.4 KANGH Business Overview
9.22.5 KANGH Recent Developments
9.23 Henan Grand Biopharma
9.23.1 Henan Grand Biopharma Human Vaccine Basic Information
9.23.2 Henan Grand Biopharma Human Vaccine Product Overview
9.23.3 Henan Grand Biopharma Human Vaccine Product Market Performance
9.23.4 Henan Grand Biopharma Business Overview
9.23.5 Henan Grand Biopharma Recent Developments
9.24 ZhongKe Biopharm
9.24.1 ZhongKe Biopharm Human Vaccine Basic Information
9.24.2 ZhongKe Biopharm Human Vaccine Product Overview
9.24.3 ZhongKe Biopharm Human Vaccine Product Market Performance
9.24.4 ZhongKe Biopharm Business Overview
9.24.5 ZhongKe Biopharm Recent Developments
9.25 Zhuoyi Biological
9.25.1 Zhuoyi Biological Human Vaccine Basic Information
9.25.2 Zhuoyi Biological Human Vaccine Product Overview
9.25.3 Zhuoyi Biological Human Vaccine Product Market Performance
9.25.4 Zhuoyi Biological Business Overview
9.25.5 Zhuoyi Biological Recent Developments
10 HUMAN VACCINE MARKET FORECAST BY REGION
10.1 Global Human Vaccine Market Size Forecast
10.2 Global Human Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Human Vaccine Market Size Forecast by Region
10.2.4 South America Human Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Human Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Vaccine by Type (2025-2030)
11.1.2 Global Human Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Vaccine by Type (2025-2030)
11.2 Global Human Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Human Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Human Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Human Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccine as of 2022)
Table 10. Global Market Human Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Vaccine Sales Sites and Area Served
Table 12. Manufacturers Human Vaccine Product Type
Table 13. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Vaccine Market Challenges
Table 22. Global Human Vaccine Sales by Type (Kilotons)
Table 23. Global Human Vaccine Market Size by Type (M USD)
Table 24. Global Human Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Human Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Human Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Vaccine Sales (Kilotons) by Application
Table 30. Global Human Vaccine Market Size by Application
Table 31. Global Human Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Human Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Vaccine Market Share by Application (2019-2024)
Table 35. Global Human Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Human Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. CNBG Human Vaccine Basic Information
Table 44. CNBG Human Vaccine Product Overview
Table 45. CNBG Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CNBG Business Overview
Table 47. CNBG Human Vaccine SWOT Analysis
Table 48. CNBG Recent Developments
Table 49. Changsheng Life Human Vaccine Basic Information
Table 50. Changsheng Life Human Vaccine Product Overview
Table 51. Changsheng Life Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Changsheng Life Business Overview
Table 53. Changsheng Life Human Vaccine SWOT Analysis
Table 54. Changsheng Life Recent Developments
Table 55. Zhifei Human Vaccine Basic Information
Table 56. Zhifei Human Vaccine Product Overview
Table 57. Zhifei Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Zhifei Human Vaccine SWOT Analysis
Table 59. Zhifei Business Overview
Table 60. Zhifei Recent Developments
Table 61. ChengDa Bio Human Vaccine Basic Information
Table 62. ChengDa Bio Human Vaccine Product Overview
Table 63. ChengDa Bio Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. ChengDa Bio Business Overview
Table 65. ChengDa Bio Recent Developments
Table 66. Kangtai Human Vaccine Basic Information
Table 67. Kangtai Human Vaccine Product Overview
Table 68. Kangtai Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Kangtai Business Overview
Table 70. Kangtai Recent Developments
Table 71. SINOVAC BIOTECH Human Vaccine Basic Information
Table 72. SINOVAC BIOTECH Human Vaccine Product Overview
Table 73. SINOVAC BIOTECH Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. SINOVAC BIOTECH Business Overview
Table 75. SINOVAC BIOTECH Recent Developments
Table 76. Hissen Human Vaccine Basic Information
Table 77. Hissen Human Vaccine Product Overview
Table 78. Hissen Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Hissen Business Overview
Table 80. Hissen Recent Developments
Table 81. Walvax Biotechnology Human Vaccine Basic Information
Table 82. Walvax Biotechnology Human Vaccine Product Overview
Table 83. Walvax Biotechnology Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Walvax Biotechnology Business Overview
Table 85. Walvax Biotechnology Recent Developments
Table 86. GSK Human Vaccine Basic Information
Table 87. GSK Human Vaccine Product Overview
Table 88. GSK Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. GSK Business Overview
Table 90. GSK Recent Developments
Table 91. SANOFI Human Vaccine Basic Information
Table 92. SANOFI Human Vaccine Product Overview
Table 93. SANOFI Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. SANOFI Business Overview
Table 95. SANOFI Recent Developments
Table 96. Rong An Human Vaccine Basic Information
Table 97. Rong An Human Vaccine Product Overview
Table 98. Rong An Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Rong An Business Overview
Table 100. Rong An Recent Developments
Table 101. NuoCheng Bio Human Vaccine Basic Information
Table 102. NuoCheng Bio Human Vaccine Product Overview
Table 103. NuoCheng Bio Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. NuoCheng Bio Business Overview
Table 105. NuoCheng Bio Recent Developments
Table 106. Hualan Bio Human Vaccine Basic Information
Table 107. Hualan Bio Human Vaccine Product Overview
Table 108. Hualan Bio Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Hualan Bio Business Overview
Table 110. Hualan Bio Recent Developments
Table 111. Tiantan biological Human Vaccine Basic Information
Table 112. Tiantan biological Human Vaccine Product Overview
Table 113. Tiantan biological Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Tiantan biological Business Overview
Table 115. Tiantan biological Recent Developments
Table 116. Changchun Baike Human Vaccine Basic Information
Table 117. Changchun Baike Human Vaccine Product Overview
Table 118. Changchun Baike Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Changchun Baike Business Overview
Table 120. Changchun Baike Recent Developments
Table 121. Adimmune Human Vaccine Basic Information
Table 122. Adimmune Human Vaccine Product Overview
Table 123. Adimmune Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Adimmune Business Overview
Table 125. Adimmune Recent Developments
Table 126. Zhongyianke Biotech Human Vaccine Basic Information
Table 127. Zhongyianke Biotech Human Vaccine Product Overview
Table 128. Zhongyianke Biotech Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Zhongyianke Biotech Business Overview
Table 130. Zhongyianke Biotech Recent Developments
Table 131. Bharat Biotech Human Vaccine Basic Information
Table 132. Bharat Biotech Human Vaccine Product Overview
Table 133. Bharat Biotech Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Bharat Biotech Business Overview
Table 135. Bharat Biotech Recent Developments
Table 136. Bavarian Nordic Human Vaccine Basic Information
Table 137. Bavarian Nordic Human Vaccine Product Overview
Table 138. Bavarian Nordic Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Bavarian Nordic Business Overview
Table 140. Bavarian Nordic Recent Developments
Table 141. Sanofi-Pasteur Human Vaccine Basic Information
Table 142. Sanofi-Pasteur Human Vaccine Product Overview
Table 143. Sanofi-Pasteur Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Sanofi-Pasteur Business Overview
Table 145. Sanofi-Pasteur Recent Developments
Table 146. Indian Immunologicals Human Vaccine Basic Information
Table 147. Indian Immunologicals Human Vaccine Product Overview
Table 148. Indian Immunologicals Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. Indian Immunologicals Business Overview
Table 150. Indian Immunologicals Recent Developments
Table 151. KANGH Human Vaccine Basic Information
Table 152. KANGH Human Vaccine Product Overview
Table 153. KANGH Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 154. KANGH Business Overview
Table 155. KANGH Recent Developments
Table 156. Henan Grand Biopharma Human Vaccine Basic Information
Table 157. Henan Grand Biopharma Human Vaccine Product Overview
Table 158. Henan Grand Biopharma Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 159. Henan Grand Biopharma Business Overview
Table 160. Henan Grand Biopharma Recent Developments
Table 161. ZhongKe Biopharm Human Vaccine Basic Information
Table 162. ZhongKe Biopharm Human Vaccine Product Overview
Table 163. ZhongKe Biopharm Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 164. ZhongKe Biopharm Business Overview
Table 165. ZhongKe Biopharm Recent Developments
Table 166. Zhuoyi Biological Human Vaccine Basic Information
Table 167. Zhuoyi Biological Human Vaccine Product Overview
Table 168. Zhuoyi Biological Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 169. Zhuoyi Biological Business Overview
Table 170. Zhuoyi Biological Recent Developments
Table 171. Global Human Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 172. Global Human Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 173. North America Human Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 174. North America Human Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 175. Europe Human Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 176. Europe Human Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 177. Asia Pacific Human Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 178. Asia Pacific Human Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 179. South America Human Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 180. South America Human Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 181. Middle East and Africa Human Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 182. Middle East and Africa Human Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 183. Global Human Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 184. Global Human Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 185. Global Human Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 186. Global Human Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 187. Global Human Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Human Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccine as of 2022)
Table 10. Global Market Human Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Vaccine Sales Sites and Area Served
Table 12. Manufacturers Human Vaccine Product Type
Table 13. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Vaccine Market Challenges
Table 22. Global Human Vaccine Sales by Type (Kilotons)
Table 23. Global Human Vaccine Market Size by Type (M USD)
Table 24. Global Human Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Human Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Human Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Vaccine Sales (Kilotons) by Application
Table 30. Global Human Vaccine Market Size by Application
Table 31. Global Human Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Human Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Vaccine Market Share by Application (2019-2024)
Table 35. Global Human Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Human Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. CNBG Human Vaccine Basic Information
Table 44. CNBG Human Vaccine Product Overview
Table 45. CNBG Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CNBG Business Overview
Table 47. CNBG Human Vaccine SWOT Analysis
Table 48. CNBG Recent Developments
Table 49. Changsheng Life Human Vaccine Basic Information
Table 50. Changsheng Life Human Vaccine Product Overview
Table 51. Changsheng Life Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Changsheng Life Business Overview
Table 53. Changsheng Life Human Vaccine SWOT Analysis
Table 54. Changsheng Life Recent Developments
Table 55. Zhifei Human Vaccine Basic Information
Table 56. Zhifei Human Vaccine Product Overview
Table 57. Zhifei Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Zhifei Human Vaccine SWOT Analysis
Table 59. Zhifei Business Overview
Table 60. Zhifei Recent Developments
Table 61. ChengDa Bio Human Vaccine Basic Information
Table 62. ChengDa Bio Human Vaccine Product Overview
Table 63. ChengDa Bio Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. ChengDa Bio Business Overview
Table 65. ChengDa Bio Recent Developments
Table 66. Kangtai Human Vaccine Basic Information
Table 67. Kangtai Human Vaccine Product Overview
Table 68. Kangtai Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Kangtai Business Overview
Table 70. Kangtai Recent Developments
Table 71. SINOVAC BIOTECH Human Vaccine Basic Information
Table 72. SINOVAC BIOTECH Human Vaccine Product Overview
Table 73. SINOVAC BIOTECH Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. SINOVAC BIOTECH Business Overview
Table 75. SINOVAC BIOTECH Recent Developments
Table 76. Hissen Human Vaccine Basic Information
Table 77. Hissen Human Vaccine Product Overview
Table 78. Hissen Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Hissen Business Overview
Table 80. Hissen Recent Developments
Table 81. Walvax Biotechnology Human Vaccine Basic Information
Table 82. Walvax Biotechnology Human Vaccine Product Overview
Table 83. Walvax Biotechnology Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Walvax Biotechnology Business Overview
Table 85. Walvax Biotechnology Recent Developments
Table 86. GSK Human Vaccine Basic Information
Table 87. GSK Human Vaccine Product Overview
Table 88. GSK Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. GSK Business Overview
Table 90. GSK Recent Developments
Table 91. SANOFI Human Vaccine Basic Information
Table 92. SANOFI Human Vaccine Product Overview
Table 93. SANOFI Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. SANOFI Business Overview
Table 95. SANOFI Recent Developments
Table 96. Rong An Human Vaccine Basic Information
Table 97. Rong An Human Vaccine Product Overview
Table 98. Rong An Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Rong An Business Overview
Table 100. Rong An Recent Developments
Table 101. NuoCheng Bio Human Vaccine Basic Information
Table 102. NuoCheng Bio Human Vaccine Product Overview
Table 103. NuoCheng Bio Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. NuoCheng Bio Business Overview
Table 105. NuoCheng Bio Recent Developments
Table 106. Hualan Bio Human Vaccine Basic Information
Table 107. Hualan Bio Human Vaccine Product Overview
Table 108. Hualan Bio Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Hualan Bio Business Overview
Table 110. Hualan Bio Recent Developments
Table 111. Tiantan biological Human Vaccine Basic Information
Table 112. Tiantan biological Human Vaccine Product Overview
Table 113. Tiantan biological Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Tiantan biological Business Overview
Table 115. Tiantan biological Recent Developments
Table 116. Changchun Baike Human Vaccine Basic Information
Table 117. Changchun Baike Human Vaccine Product Overview
Table 118. Changchun Baike Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Changchun Baike Business Overview
Table 120. Changchun Baike Recent Developments
Table 121. Adimmune Human Vaccine Basic Information
Table 122. Adimmune Human Vaccine Product Overview
Table 123. Adimmune Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Adimmune Business Overview
Table 125. Adimmune Recent Developments
Table 126. Zhongyianke Biotech Human Vaccine Basic Information
Table 127. Zhongyianke Biotech Human Vaccine Product Overview
Table 128. Zhongyianke Biotech Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Zhongyianke Biotech Business Overview
Table 130. Zhongyianke Biotech Recent Developments
Table 131. Bharat Biotech Human Vaccine Basic Information
Table 132. Bharat Biotech Human Vaccine Product Overview
Table 133. Bharat Biotech Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Bharat Biotech Business Overview
Table 135. Bharat Biotech Recent Developments
Table 136. Bavarian Nordic Human Vaccine Basic Information
Table 137. Bavarian Nordic Human Vaccine Product Overview
Table 138. Bavarian Nordic Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Bavarian Nordic Business Overview
Table 140. Bavarian Nordic Recent Developments
Table 141. Sanofi-Pasteur Human Vaccine Basic Information
Table 142. Sanofi-Pasteur Human Vaccine Product Overview
Table 143. Sanofi-Pasteur Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Sanofi-Pasteur Business Overview
Table 145. Sanofi-Pasteur Recent Developments
Table 146. Indian Immunologicals Human Vaccine Basic Information
Table 147. Indian Immunologicals Human Vaccine Product Overview
Table 148. Indian Immunologicals Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. Indian Immunologicals Business Overview
Table 150. Indian Immunologicals Recent Developments
Table 151. KANGH Human Vaccine Basic Information
Table 152. KANGH Human Vaccine Product Overview
Table 153. KANGH Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 154. KANGH Business Overview
Table 155. KANGH Recent Developments
Table 156. Henan Grand Biopharma Human Vaccine Basic Information
Table 157. Henan Grand Biopharma Human Vaccine Product Overview
Table 158. Henan Grand Biopharma Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 159. Henan Grand Biopharma Business Overview
Table 160. Henan Grand Biopharma Recent Developments
Table 161. ZhongKe Biopharm Human Vaccine Basic Information
Table 162. ZhongKe Biopharm Human Vaccine Product Overview
Table 163. ZhongKe Biopharm Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 164. ZhongKe Biopharm Business Overview
Table 165. ZhongKe Biopharm Recent Developments
Table 166. Zhuoyi Biological Human Vaccine Basic Information
Table 167. Zhuoyi Biological Human Vaccine Product Overview
Table 168. Zhuoyi Biological Human Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 169. Zhuoyi Biological Business Overview
Table 170. Zhuoyi Biological Recent Developments
Table 171. Global Human Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 172. Global Human Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 173. North America Human Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 174. North America Human Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 175. Europe Human Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 176. Europe Human Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 177. Asia Pacific Human Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 178. Asia Pacific Human Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 179. South America Human Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 180. South America Human Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 181. Middle East and Africa Human Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 182. Middle East and Africa Human Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 183. Global Human Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 184. Global Human Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 185. Global Human Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 186. Global Human Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 187. Global Human Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Human Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Human Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Human Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Vaccine Market Size by Country (M USD)
Figure 11. Human Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Human Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Vaccine Market Share by Type
Figure 18. Sales Market Share of Human Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Human Vaccine by Type in 2023
Figure 20. Market Size Share of Human Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Human Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Vaccine Market Share by Application
Figure 24. Global Human Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Human Vaccine Sales Market Share by Application in 2023
Figure 26. Global Human Vaccine Market Share by Application (2019-2024)
Figure 27. Global Human Vaccine Market Share by Application in 2023
Figure 28. Global Human Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Vaccine Sales Market Share by Region in 2023
Figure 44. China Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Human Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Human Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Human Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Human Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Human Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Vaccine Market Size by Country (M USD)
Figure 11. Human Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Human Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Vaccine Market Share by Type
Figure 18. Sales Market Share of Human Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Human Vaccine by Type in 2023
Figure 20. Market Size Share of Human Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Human Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Vaccine Market Share by Application
Figure 24. Global Human Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Human Vaccine Sales Market Share by Application in 2023
Figure 26. Global Human Vaccine Market Share by Application (2019-2024)
Figure 27. Global Human Vaccine Market Share by Application in 2023
Figure 28. Global Human Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Vaccine Sales Market Share by Region in 2023
Figure 44. China Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Human Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Human Vaccine Market Share Forecast by Application (2025-2030)
